FDA Accepts Salix's Latest New Drug Application

Published February 2, 2014

FDA accepts Salix's latest new drug application
The FDA expects to issue a ruling on the application on Sept. 15. Raleigh-based Salix sells drugs to treat gastrointestinal ailments. Earlier this year, Salix completed its $ 2.6 billion acquisition of the specialty drug company Santarus, which focuses …
Read more on News & Observer

FDA accepts new drug filing for Salix rectal inflammation drug
Raleigh, N.C. — A proposed treatment for a difficult to threat form of rectal inflammation from Salix Pharmaceuticals is moving closer to approval by the FDA. Salix (NASDAQ: SLXP) said early Thursday that the FDA has accepted a New Drug Application.
Read more on WRAL Tech Wire

Triangle schools, businesses deal with growing popularity of e-cigarettes
RALEIGH — The Wake County school board is expected to vote Tuesday on whether to ban something that many parents probably already thought was against the rules: electronic cigarettes. Duke University has … “But I don't like to be the center of …
Read more on News & Observer

Find More Drug Treatment Centers Raleigh Nc Information…